I run my own portfolio. I read the 10-Ks. I still wanted a second opinion — the kind you can’t get from a brokerage chatbot.
Three tools claim to give it: Magnifi (a conversational AI copilot), Danelfin (a 1-10 AI stock score), and TradingView’s community-built AI indicators. In this Magnifi vs Danelfin vs TradingView AI comparison, different prices and different pitches share the same promise — smarter decisions.
So I gave all three the exact same portfolio and asked the same question: what should I change in the next 30 days? Among AI stock screener tools in 2026, these three get the most search traffic — but traffic doesn’t mean useful.
Spoiler that isn’t a spoiler: one of them flagged a position I was about to hold through a dividend cut. Whether that’s worth $20 a month is a different question — and the more interesting one.
What Each Tool Actually Does (in 90 Seconds)
Two of these get pitched as direct competitors. They aren’t.
Magnifi is a chat interface bolted onto investing data. You ask “is my portfolio too tech-heavy?” and it answers in plain English, with charts. The free tier exists but is hobbled by delayed data; the real product is $14.99/month. In this Magnifi AI investing review, it plays the role of portfolio coach.
Danelfin is a 1-10 AI score on individual stocks and ETFs, generated from 900+ technical and fundamental indicators with an “explainable AI” layer showing which factors drove the score. Free for delayed scores, $19.99/month for real-time data and unlimited searches.
TradingView is not an AI screener. It’s the dominant charting platform globally, and the “AI” everyone references is community-built Pine Script indicators — neural-net trend detectors, ML classifiers, sentiment overlays. Among TradingView AI features in 2026, the base paid plan starts at $14.95/month, but the AI scripts themselves are mostly free and wildly uneven in quality.
Honest framing: only Magnifi and Danelfin are AI products the way most readers picture them. TradingView is a chart platform that hosts AI scripts the same way a phone hosts apps — the platform isn’t doing the work, the script is.
Which means a fair comparison is harder than the SERP suggests.
The Test: Same Portfolio, Same Question, Three AI Stock Screener Tools
If I’m going to call a winner, the test has to be the same for all three.
The portfolio: a VOO core with five individual positions — one megacap tech name, a regional bank, a healthcare ETF, a dividend-paying staple, and one speculative growth pick. Roughly what a 35-year-old with a real job and a real brokerage account actually holds. (You can replicate a basic version of this test by exporting your holdings and learning to analyze your portfolio CSV in ChatGPT — it won’t replace a screener, but it’s free and surprisingly capable.)
The question, identical to each tool: Review this portfolio. Tell me one thing I should change in the next 30 days, and why.
What I was grading on: did the AI surface something specific and actionable I hadn’t already considered? Not “you’re overweight tech” — I know I’m overweight tech. Something that would have changed a decision.
Bonus probe: I asked each tool to evaluate the speculative growth pick on its own. If AI scoring is real, three different models scoring the same stock should disagree in interesting ways — not converge on the same consensus you’d get from a free brokerage research tab.
Same inputs, same prompt, same week. Most AI-powered stock analysis comparisons let each product play its strength. This test made each one fail at the same job.
What Each AI Said, Ranked by “Was This Actually Useful?”
Danelfin — most useful in this test. The regional bank held a 7 score when I added it; six weeks later, it had dropped to 4. The explanation layer pointed to deteriorating earnings revisions and a sentiment factor that had reversed sharply. In Danelfin AI stock picks reviews, this kind of score movement is the core signal — and it was right. I’d been treating the position as a long-term hold. A week after I trimmed it, the bank cut its dividend and dropped 12%. Whether Danelfin “predicted” the cut or just caught the same signals a careful human would have, I don’t know. What I know is that I wasn’t reading those signals, and the score made me re-read them. That’s the job of a tool.
Magnifi — second most useful. Magnifi didn’t surface anything I didn’t know about specific holdings. But its portfolio-level analysis was the best of the three. It pointed out that my “diversified” portfolio had over 60% correlated exposure to interest-rate-sensitive assets — bank, dividend-payer, healthcare ETF, even the megacap tech name all moving together when the Fed surprises. I’d never articulated it that way, and the conversational layer let me pressure-test the framing by asking follow-ups. Like the iteration loop in a Claude vs ChatGPT writing test, the value wasn’t the answer — it was the second and third question.
TradingView — least useful, but not its fault. I asked a portfolio-review question of a charting platform. The two community AI indicators I tried — a popular ML trend-detection script and a sentiment overlay — gave me chart signals on individual tickers, not portfolio advice. The signals were fine. They were also the wrong answer to the wrong question. If you’re a technical trader, TradingView dominates this category. If you’re a long-term investor running a portfolio review, you’re hiring the wrong tool.
Quick verdict: Danelfin wins on stock-level insight. Magnifi wins on portfolio reasoning. TradingView is excellent at the job nobody in this article is hiring it for. In this Magnifi vs Danelfin vs TradingView AI breakdown, the separation is clear — they’re built for different investors.
The Question Nobody Wants to Ask: Did Any of This Beat the Index?
Here’s where most comparison articles get suspiciously quiet.
The Danelfin save was real money. Call it a 12% drawdown avoided on that single position. Run the math against the whole portfolio and it’s worth roughly 0.6% of total value. Subtract $240/year for Danelfin Pro, subtract the four hours I spent on the test, and the “edge” gets very thin very fast.
Over the past twelve months, the actively-managed sleeve of my portfolio underperformed VOO by about two percent. The AI tools did not change that. They made me feel more informed while underperforming.
I’m not saying these tools don’t work. I’m saying they don’t manufacture conviction you don’t already have. When AI screeners are worth it: you already pick individual stocks, you want a structured second opinion, and you’ll act on it. When they aren’t: “I subscribed to an AI tool” is the reason you started picking individual stocks. Don’t let the subscription create the behavior. Most AI portfolio analysis tools share this trait.
That’s the rule I’d apply to most AI automations, too — the tool amplifies a workflow you already have. It does not supply one.
The Bottom Line: Which One to Actually Pay For
If you already hold individual stocks: Danelfin. The score plus the explainable factors is the only thing in this test that flat-out earned its $19.99. Use it as a triage layer — anything that drops two points in six weeks goes on your re-read list.
If you mostly index but want a portfolio coach: Magnifi. The conversational layer is the most approachable AI I’ve used for personal finance, and the correlation framing is genuinely useful. Worth $14.99 if you’ll actually open it monthly. If you’re looking for the best AI investment analysis tool for portfolio-level reasoning, Magnifi is it.
If you’re a technical trader: TradingView, but pay for the charts and ignore the AI label. Treat the community AI scripts as experiments. Some are excellent. None are signals.
And if you’re not already an active investor: skip all three. Buy VOO. Add to it monthly. For the spending side of your finances, the AI budgeting apps I tested for 90 days told a similar story about subscription value. Come back to this Magnifi vs Danelfin vs TradingView AI question when you have enough conviction in a real stock to want a second opinion — because that’s the only condition under which any of these tools pay for themselves. The thing that almost saved me money wasn’t AI. It was paying attention.